Qingdao Historical Income Statement

688139 Stock   33.78  0.67  2.02%   
Historical analysis of Qingdao Haier income statement accounts such as Net Interest Income of 37.7 M, Interest Expense of 4.2 M or Selling General Administrative of 241.6 M can show how well Qingdao Haier Biomedical performed in making a profits. Evaluating Qingdao Haier income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Qingdao Haier's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Qingdao Haier Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Qingdao Haier Biomedical is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Qingdao Haier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Qingdao Income Statement Analysis

Qingdao Haier Biomedical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Qingdao Haier shareholders. The income statement also shows Qingdao investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Qingdao Haier Income Statement Chart

At present, Qingdao Haier's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 37.7 M, whereas Selling General Administrative is forecasted to decline to about 241.6 M.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Qingdao Haier Biomedical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Qingdao Haier Biomedical minus its cost of goods sold. It is profit before Qingdao Haier operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Qingdao Haier's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Qingdao Haier Biomedical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Qingdao Haier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Qingdao Haier's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 37.7 M, whereas Selling General Administrative is forecasted to decline to about 241.6 M.
 2022 2023 2024 2025 (projected)
Gross Profit1.4B1.2B1.3B806.0M
Total Revenue2.9B2.3B2.6B1.6B

Qingdao Haier income statement Correlations

0.140.680.580.57-0.350.720.880.570.460.590.540.90.880.83-0.510.20.730.3
0.140.40.590.6-0.40.570.470.780.710.580.580.440.470.44-0.490.830.550.75
0.680.40.930.92-0.590.90.830.780.830.930.920.830.830.8-0.810.640.860.67
0.580.590.931.0-0.590.950.870.90.911.01.00.850.870.86-0.860.770.950.81
0.570.60.921.0-0.60.940.870.90.911.01.00.850.870.86-0.850.780.950.82
-0.35-0.4-0.59-0.59-0.6-0.51-0.48-0.59-0.64-0.58-0.6-0.47-0.48-0.550.75-0.52-0.56-0.62
0.720.570.90.950.94-0.510.930.880.810.950.920.920.930.85-0.810.640.920.68
0.880.470.830.870.87-0.480.930.850.750.870.851.01.00.97-0.740.540.960.63
0.570.780.780.90.9-0.590.880.850.950.90.890.830.850.83-0.820.870.90.92
0.460.710.830.910.91-0.640.810.750.950.90.920.730.750.77-0.840.920.870.96
0.590.580.931.01.0-0.580.950.870.90.91.00.860.870.85-0.870.750.940.8
0.540.580.921.01.0-0.60.920.850.890.921.00.830.840.85-0.860.780.940.83
0.90.440.830.850.85-0.470.921.00.830.730.860.831.00.96-0.730.520.940.61
0.880.470.830.870.87-0.480.931.00.850.750.870.841.00.97-0.740.540.950.63
0.830.440.80.860.86-0.550.850.970.830.770.850.850.960.97-0.740.560.970.68
-0.51-0.49-0.81-0.86-0.850.75-0.81-0.74-0.82-0.84-0.87-0.86-0.73-0.74-0.74-0.62-0.8-0.82
0.20.830.640.770.78-0.520.640.540.870.920.750.780.520.540.56-0.620.70.92
0.730.550.860.950.95-0.560.920.960.90.870.940.940.940.950.97-0.80.70.78
0.30.750.670.810.82-0.620.680.630.920.960.80.830.610.630.68-0.820.920.78
Click cells to compare fundamentals

Qingdao Haier Account Relationship Matchups

Qingdao Haier income statement Accounts

202020212022202320242025 (projected)
Tax Provision40.1M111.7M63.4M22.4M25.8M45.9M
Net Interest Income22.9M7.7M16.7M31.3M35.9M37.7M
Interest Expense83.4K2.9M2.7M3.5M3.2M4.2M
Selling General Administrative190.7M295.4M402.6M231.0M265.7M241.6M
Total Revenue1.4B2.1B2.9B2.3B2.6B1.6B
Gross Profit707.9M1.1B1.4B1.2B1.3B806.0M
Other Operating Expenses5.9M221.1K13.0M1.6M1.5M1.4M
Operating Income321.7M463.5M594.5M343.1M394.5M306.7M
Net Income From Continuing Ops384.1M849.2M612.0M412.1M473.9M376.6M
Ebit102.2M196.6M303.0M442.0M508.3M533.7M
Research Development150.7M236.3M292.5M320.6M368.7M387.2M
Cost Of Revenue694.1M1.1B1.5B1.1B1.3B793.2M
Total Operating Expenses1.1B1.7B2.3B1.9B2.2B1.3B
Income Before Tax424.2M960.9M675.3M434.5M499.7M422.5M
Net Income Applicable To Common Shares114.0M182.1M381.0M600.8M690.9M725.5M
Net Income381.0M845.0M600.8M406.1M467.0M373.0M
Income Tax Expense27.7M40.1M111.7M63.4M72.9M49.0M
Minority Interest8.6M(4.1M)(11.2M)(6.0M)(5.4M)(5.1M)
Interest Income23.2M10.7M20.3M35.6M41.0M43.0M
Ebitda222.8M447.2M1.0B742.1M853.4M496.4M
Reconciled Depreciation22.9M51.0M64.1M103.4M119.0M124.9M

Currently Active Assets on Macroaxis

Other Information on Investing in Qingdao Stock

Qingdao Haier Biomedical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Qingdao Haier shareholders. The income statement also shows Qingdao investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).